Mission Bio
PrivateLast Round
Early Funding
Aug 5, 2025
Total Funding Raised
$112M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mission Bio operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was an Early Funding round in August 2025.
Mission Bio is a life sciences company that develops and commercializes the Tapestri Platform, a precision genomics tool for high-throughput single-cell multi-omics analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mission Bio Comparables
Compare Mission Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSkryb Genomics | 87% | |
| Singleron Biotechnologies | 84% | |
| Beijing SeekGene BioSciences Co., Ltd. | 83% |
For institutional investors. Book with your work email.
Mission Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 5, 2025 | ||||
| Series C | Aug 13, 2020 | ||||
| Grant | Oct 10, 2019 | ||||
| Series B | Dec 13, 2018 | ||||
| Series A | Oct 17, 2017 | ||||
Seed | Feb 6, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mission Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series C |
| Cota Capital | Early Funding, Series B, Series C |
| National Cancer Institute | Grant |
| StartX | Series A |
| Keiretsu Forum | Series A, Seed |
| Ally Bridge Group | Early Funding |
| Agilent Ventures | Early Funding, Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 45% MoM, reaching 12.8K.
- Nov 20, 2025
New product announced at the ASH 2025 conference.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientSep 28, 2026
Mission Bio signed Merck Group as a new client after Merck Group selected the Tapestri Platform and partnered with its Assay Services team to build a targeted DNA and RNA single-cell assay.
- attends_eventSep 28, 2026
Mission Bio showcases Tapestri across drug discovery and clinical development at the 16th World Clinical Biomarkers & Companion Diagnostics Summit (World CDx) on Oct 8th '26.
For institutional investors. Book with your work email.
Mission Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mission Bio's valuation, stock price, and market status.
Is Mission Bio a public or private company?
Mission Bio is a private company.
What is the current stock price of Mission Bio?
Mission Bio is a private company, so its shares have no public market price. Caplight tracks Mission Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mission Bio worth (valuation)?
Valuation information for Mission Bio is not publicly available.
Can I buy Mission Bio stock?
Mission Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mission Bio's last funding round?
Mission Bio's most recent funding round was Early Funding on August 5, 2025.
Who are the main investors in Mission Bio?
Key investors in Mission Bio include Ally Bridge Group, Novo Growth, Life Science Angels, Mayfield Fund.
Will Mission Bio IPO soon?
No public IPO plans have been announced for Mission Bio.
How can I track Mission Bio secondary market activity?
Caplight tracks bids, offers, and trades in Mission Bio's shares on secondary markets.